Makers of Januvia and Byetta Accused of Hiding Pancreatic Cancer Risk

SAN DIEGO — A man has sued the makers of Januvia and Byetta in California court, accusing them of concealing the risk of pancreatic cancer posed by the type 2 diabetes drugs.

The complaint, pending in the U.S. District Court for the Southern District of California, says Merck & Co. Inc. (NYSE: MRK), Amylin Pharmaceuticals Inc. and Eli Lilly & Co. (NYSE: LLY) willfully and negligently failed to warn doctors and the public that the drugs were not safe for their intended use.

Moses Scott originally filed the Sept. 28 complaint in the San Diego County Superior Court, alleging that …